Clinical Trials · NCT05073692
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Kaiser Permanente
- Enrollment
- 241,981
- Start date
- Jul 2021
- Locations
- 6 sites, United States
- Primary endpoint
- Incidence of 3-point Major Adverse Cardiovascular Events (MACE)